Retinoblastoma gene expression in human non-melanoma skin cancer (Q40638710)

22 September 2017

title

Retinoblastoma gene expression in human non-melanoma skin cancer (English)

1 reference

22 September 2017

1 reference

Malcolm J Edwards

1

1 reference

22 September 2017

R C Thomas

series ordinal

2

1 reference

22 September 2017

Y L Wong

series ordinal

3

1 reference

22 September 2017

publication date

1 September 2003

1 reference

Journal of Cutaneous Pathology

22 September 2017

published in

1 reference

22 September 2017

volume

30

1 reference

22 September 2017

issue

8

1 reference

22 September 2017

page(s)

479-485

1 reference

Mammalian G1- and S-phase checkpoints in response to DNA damage

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Regulation and function of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Cell cycle checkpoint signaling through the ATM and ATR kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma protein pathway and the restriction point

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Pathways governing G1/S transition and their response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Specific enzymatic dephosphorylation of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma protein binds to a family of E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The retinoblastoma gene family in differentiation and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

P16 UV mutations in human skin epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Combined analysis of p53 and retinoblastoma protein expressions in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

Loss of p14ARF expression in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Inactivation of the retinoblastoma susceptibility gene in human breast cancers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Role of pRB dephosphorylation in cell cycle regulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

The E2F transcription factor is a cellular target for the RB protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

E2F-induced S phase requires cyclin E.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Physical interaction of the retinoblastoma protein with human D cyclins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Opposing roles of pRB and p107 in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.00004.X

7 January 2021

10.1034/J.1600-0560.2003.00004.X

Identifiers

DOI

1 reference

22 September 2017

1 reference